more predictable safety profile Commercial Status: Retatrutide: Not yet marketed Zepbound: Blockbuster franchise part of the tirzepatide portfolio generating tens of billions in revenue Clinical Positioning: Retatrutide: Potential next-generation, high-efficacy option Zepbound: Current standard among incretin-based obesity therapies Strategic Role (Lilly Portfolio): Retatrutide: Potential lifecycle successor to tirzepatide Zepbound: Current market leader and revenue driver Key Trade-Off: Retatrutide: Higher efficacy vs
However, if you experience severe pain, persistent burning, or signs of injection site reactions, contact your GP or prescribing clinician for advice
Take a balanced diet and stay in contact with your doctor to manage these effects in order to prevent further complications
They were like and I was, well, I wasnt shocked
Higher than that is not recommended
While it was originally developed to help individuals managing alcohol or opioid use disorders, it has found a significant place in weight management